App company failed to produce a working application

The goal of this pragmatic multicentre clinical trial is to investigate whether telemonitoring with Rheum@Home leads to less outpatient visits, while maintaining tight disease control and high patient-experienced quality of care in patients with rheumatoid arthritis.

Participants will be asked to

• complete questionaires every 4 weeks
• perform a walking test every 4 weeks
• routine lab
• routine disease activity measurement by a qualified assessor

Researchers will compare care via the telemedicine system (intervention) or standard care (control) to see if there are differences in the number of rheumatology outpatient visits and patient reported quality of care after 12 months follow up.

Inclusion Criteria:

• all consecutive patients;
• signed, written informed consent;
• 18 -75 years of age;
• clinical diagnosis of RA;
• ≥ 6 months stable low disease activity or remission, according to the treating rheumatologist;
• able to read and understand simple Dutch language instructions;
• ownership or access to a smartphone, tablet or computer and having internet access;
• able to conduct a teleconsultation on a smartphone, tablet or computer.

Exclusion Criteria:

• severe comorbidity or other factors necessitating continuation of regular outpatient visits, according to the treating rheumatologist

All collected IPD

After publication

Upon reasonable request to p.m.tenklooster@utwente.nl